Things could be looking ok in the not to distant future. A pause and even reversal of interest rates, some saying the latter could happen this year. There has already been some huge M&A activity this year in the bio space, Seagen obviously springs to mind. We should see more of this with a lot of big pharma drugs about to reach the end of their patent life.
A tough 18 months or so in the space but things will turn around. Whether CHM can stretch things out until some of these things happen, I’m not sure.
CHM Price at posting:
6.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)